TMO
April 23, 2025 - AI Summary
Undervalued by 58.1% based on the discounted cash flow analysis.
Market cap | $152.18 Billion |
---|---|
Enterprise Value | $182.23 Billion |
Dividend Yield | $1.6 (0.396894302086176%) |
Earnings per Share | $16.58 |
Beta | 0.83 |
Outstanding Shares | 378,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 23.39 |
---|---|
PEG | 173.53 |
Price to Sales | 3.8 |
Price to Book Ratio | 3.3 |
Enterprise Value to Revenue | 4.25 |
Enterprise Value to EBIT | 28.81 |
Enterprise Value to Net Income | 27 |
Total Debt to Enterprise | 0.19 |
Debt to Equity | 0.69 |
No data
No data
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are acceleratin...